Kapitalo Investimentos Ltda Virax Biolabs Group LTD Transaction History

Kapitalo Investimentos Ltda

  • $410 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Mar 29, 2024
SELL
$0.64 - $1.21 $75,200 - $142,175
-117,500 Closed
0 $0
Q4 2022

Mar 29, 2024
BUY
$0.57 - $28.6 $66,975 - $3.36 Million
117,500 New
117,500 $858 Million

About Virax Biolabs Group Ltd

VRAX Quotes by TradingView
  • Ticker VRAX
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,374,100
  • Market Cap $20.4M
  • Description
  • Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...
More about VRAX
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email